Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Markers for Increased Thrombotic Risk within the Complete Blood Count

Sæmundur Rögnvaldsson, Sigrún H. Lund, PhD, Malin Hultcrantz, MD PhD, Signý Vala Sveinsdóttir, MD PhD, Guðný Eiríksdóttir, Tamara B Harris, MD, Vilmundur Guðnason, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 1429.

https://doi.org/10.1182/blood.V128.22.1429.1429

Published: 2016

Journal Articles

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Gudbjorg Jonsdottir, MD, Sigrún H. Lund, PhD, Magnus Björkholm, MD, PhD, Ingemar Turesson, MD, PhD, Anders Wahlin, MD, Prof., Malin Hultcrantz, MD, PhD, Anna Porwit, MD, PhD, Ola Landgren, MD, PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 3246.

https://doi.org/10.1182/blood.V128.22.3246.3246

Published: 2016

Journal Articles

Dietary Pattern and Risk of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study

Marianna Thordardottir, Ebba K Lindqvist, MD, Sigrun H Lund, PhD, Rene Costello, Johanna E Torfadottir, PhD, Bryndis E Birgisdottir, PhD, Debra Burton, Laufey Steingrimsdottir, PhD, Neha S Korde, MD, Sham Mailankody, MD, Gudny Eiriksdottir, Lenore J Launer, PhD, Tamara B Harris, MD, Ola Landgren, MDPhD, Vilmundur Gudnason, MDPhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 3257.

https://doi.org/10.1182/blood.V128.22.3257.3257

Published: 2016

Journal Articles

Risk of Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS): Results from a Population-Based Screening Study

Ebba K Lindqvist, MD, Sigrun H Lund, PhD, Rene Costello, Debra Burton, Neha S Korde, MD, Sham Mailankody, MD, Magnus Björkholm, MD, PhD, Gudny Eiriksdottir, Leonore J Launer, PhD, Tamara B Harris, MD, Malin Hultcrantz, MDPhD, Vilmundur Gudnason, MD PhD, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 5650.

https://doi.org/10.1182/blood.V128.22.5650.5650

Published: 2016

Journal Articles

Improved Survival in AL Amyloidosis: A Population-Based Study on 1,430 Patients Diagnosed in Sweden 1995-2013

Brendan M. Weiss, MD, Sigrun H Lund, PhD, Magnus Bjorkholm, Adam D. Cohen, MD, Laura Dember, MD, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 4448.

https://doi.org/10.1182/blood.V128.22.4448.4448

Published: 2016

Journal Articles

No Risk of Arterial or Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance: Results from a Population-Based Study

Ebba K Lindqvist, MD, Sigrún H. Lund, PhD, Rene Costello, Debra Burton, Neha S Korde, MD, Sham Mailankody, MBBS, Vilmundur Gudnason, MD PhD, Gudny Eiriksdottir, Leonore Launer, PhD, Tamara B Harris, MD, Malin Hultcrantz, MDPhD, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD PhD, Magnus Bjorkholm, MD PhD

Blood (2015) 126 (23): 4252.

https://doi.org/10.1182/blood.V126.23.4252.4252

Published: 2015

Journal Articles

Thromboembolism and Clinically Relevant Bleeding in Relation to Warfarin Anticoagulation Variability in Patients Monitored with Either Fiix-Prothrombin Time or Quick-Prothrombin Time. the Fiix-Trial

Alma R. Oskarsdottir, BS, Brynja R. Gudmundsdottir, MS, Olafur S. Indridason, MD MPH, Hulda M. Jensdottir, BS, David O. Arnar, MD PhD, Einar S. Bjornsson, MD PhD, Magnus K. Magnusson, MD, Sigrun H. Lund, PhD, Brynjar Vidarsson, MD, Charles W. Francis, MD, Pall T. Onundarson, MD

Blood (2015) 126 (23): 1129.

https://doi.org/10.1182/blood.V126.23.1129.1129

Published: 2015

Journal Articles

Gender Differences during Long-Term Warfarin Anticoagulation in Patients with Atrial Fibrillation Monitored with Fiix-Prothrombin Time or Prothrombin Time. the Fiix Trial

Hulda M. Jensdottir, BS, Brynjar Vidarsson, MD, Brynja R. Gudmundsdottir, MS, Alma R. Oskarsdottir, BS, Olafur S. Indridason, MD MPH, David O. Arnar, MD PhD, Einar S. Bjornsson, MD PhD, Magnus K. Magnusson, MD, Sigrun H. Lund, PhD, Charles W. Francis, MD, Pall T. Onundarson, MD

Blood (2015) 126 (23): 1134.

https://doi.org/10.1182/blood.V126.23.1134.1134

Published: 2015

Journal Articles

Impact Of History Of Autoimmune Disease On Survival In Multiple Myeloma and Monoclonal Gammopathy Of Undetermined Significance: A Population-Based Study

Ebba K Lindqvist, MD, PhD Student, Ingemar Turesson, MD, PhD, Ola Landgren, MD, PhD, Sigrún H Lund, PhD, Lynn Goldin, PhD, Magnus Bjorkholm, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2013) 122 (21): 1898.

https://doi.org/10.1182/blood.V122.21.1898.1898

Published: 2013

NARROW

Markers for Increased Thrombotic Risk within the Complete Blood Count

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Dietary Pattern and Risk of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study

Risk of Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS): Results from a Population-Based Screening Study

Improved Survival in AL Amyloidosis: A Population-Based Study on 1,430 Patients Diagnosed in Sweden 1995-2013

No Risk of Arterial or Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance: Results from a Population-Based Study

Thromboembolism and Clinically Relevant Bleeding in Relation to Warfarin Anticoagulation Variability in Patients Monitored with Either Fiix-Prothrombin Time or Quick-Prothrombin Time. the Fiix-Trial

Gender Differences during Long-Term Warfarin Anticoagulation in Patients with Atrial Fibrillation Monitored with Fiix-Prothrombin Time or Prothrombin Time. the Fiix Trial

Impact Of History Of Autoimmune Disease On Survival In Multiple Myeloma and Monoclonal Gammopathy Of Undetermined Significance: A Population-Based Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only